A survey of UK-based screening and surveillance practices for carcinoid heart disease in patients with neuroendocrine tumours [0.03%]
英国基于筛查和神经内分泌肿瘤患者的类癌心脏病监测实践调查
Sasha Douglas,Tahir Shah,Richard P Steeds et al.
Sasha Douglas et al.
Symptoms of carcinoid heart disease (CHD) can be subtle or absent even in advanced disease; therefore screening for CHD is important in the management of neuroendocrine tumours (NETs). Previous data in 2015 demonstrated variation in screeni...
Epidemiology, presentation and outcomes in pituitary apoplexy: a population-based study in Malta [0.03%]
马耳他的一项基于人群的垂体卒中的流行病学、临床表现及转归研究
Lianne Camilleri,Josanne Vassallo,Mark Gruppetta
Lianne Camilleri
Aims and objectives: To determine the prevalence, incidence, and outcomes of pituitary apoplexy patients presenting acutely in Malta. Methodology: ...
Enucleation for pancreatic neuroendocrine tumors: short- and long-term outcomes in a forty-year single-center experience [0.03%]
胰腺神经内分泌肿瘤的剜出术：40年单中心经验和短期及长期结果分析
Anna Caterina Milanetto,Eugenio De Carlo,Daniele Gasparini et al.
Anna Caterina Milanetto et al.
Background: Surgery plays a key role in the treatment of pancreatic neuroendocrine tumors (PanNETs). Enucleation combines a radical resection with the sparing of healthy pancreatic parenchyma. ...
Impact of single nucleotide variants in estrogen genes on ovarian cancer risk: a systematic review and meta-analysis [0.03%]
雌激素基因单核苷酸多态性与卵巢癌风险的关联：系统评价和meta分析
M P Aguiar,M O Gomes,L F Ananias et al.
M P Aguiar et al.
Ovarian cancer research increasingly emphasizes the role of genetic factors, particularly estrogen, a key hormone also implicated in breast cancer. Hypotheses such as incessant ovulation and hormonal stimulation of ovarian epithelial cells ...
Bilateral and recurrent adrenocortical carcinoma in MEN1: a case report and review of the literature [0.03%]
MEN1患者的双侧和复发性肾上腺皮质癌一例报告及文献复习
Sophie Howarth,James MacFarlane,August Palma et al.
Sophie Howarth et al.
Abstract: The autosomal dominant hereditary cancer syndrome multiple endocrine neoplasia type 1 (MEN1) is associated with an increased prevalence of both benign and malignant adrenal lesions. Although MEN1 mutations are i...
177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) in metastatic phaeochromocytomas and paragangliomas (mPPGL): a single centre retrospective analysis of experience at an ENETS Centre of Excellence [0.03%]
卢道泰肽受体放射性核素治疗（PRRT）在转移性嗜铬细胞瘤和副神经节瘤（mPPGL）中的应用：一个ENETS卓越中心的经验回顾分析
Kalyan Mansukhbhai Shekhda,Eleni Armeni,Yiwang Xu et al.
Kalyan Mansukhbhai Shekhda et al.
Introduction: 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) represents a possible therapeutic option for patients with metastatic inoperable phaeochromocytomas (PCC) and paragangliomas (PGL) who demonstrate ...
Paltusotine versus octreotide: different effects on radioligand uptake in neuroendocrine tumours [0.03%]
帕鲁妥欣与奥曲肽对神经内分泌肿瘤放射配体摄取的不同影响
Katharina Wang,Christoph J Auernhammer,Simon Lindner et al.
Katharina Wang et al.
Objective: Somatostatin receptor analogues are well-established in the treatment of metastatic gastro-enteropancreatic neuroendocrine tumours (GEP-NETs), especially for symptom control in patients with the carcinoid syndr...
Success of 177Lu-DOTATATE therapy in a metastatic pituitary neuroendocrine tumor [0.03%]
177Lu-DOTATATE治疗转移性垂体神经内分泌肿瘤的疗效
Katherine I Wolf,Zhonglin Lu,Elizabeth A Hesseltine et al.
Katherine I Wolf et al.
Abstract: Metastatic pituitary neuroendocrine tumors (PitNETs) are rare and often aggressive. Patients should be evaluated for metastatic disease when their biochemical presentation is discordant with pituitary tumor burd...
Cytologically non-malignant thyroid nodules with three or more high-risk genetic mutations have poor outcomes [0.03%]
具有三种或更多高风险遗传变异的细胞学上非恶性甲状腺结节预后不良
Alexander R Goldberg,Cheng Liu,Gary D Rothberger et al.
Alexander R Goldberg et al.
Background: While traditional risk stratification for thyroid cancer primarily focused on tumor pathology, molecular profiling is increasingly recognized for its clinical relevance. There are limited data on tumors with t...
Macrophage abundance in oncocytic thyroid cancer is associated with PD-L1 expression [0.03%]
丰富巨噬细胞的甲状腺肿瘤组织与PD-L1表达相关联
Julio C Ricarte-Filho,Caitlin O Caperton,Amber Isaza et al.
Julio C Ricarte-Filho et al.
Objective: Oncocytic thyroid cancer (OTC) accounts for 3-5% of thyroid cancers. Previously classified as a subtype of follicular thyroid cancer (FTC), OTC has been redefined by the World Health Organization due to its dis...